Bionoid Pharma Inc. (OTC PINK: BINP) has announced the release of its next-generation AI prospecting engine, a technological advancement aimed at transforming sales engagement. This tool automates the research, engagement, and qualification of sales prospects, leveraging millions of data points to deliver real-time insights and enable context-aware communication. It supports both transactional and consultative sales strategies, addressing the need for efficiency and precision in sales processes.
Wayne Cockburn, CEO of Bionoid Pharma Inc., highlighted the system's ability to handle discovery, objections, and scheduling—tasks that have traditionally required human intervention. This AI-driven platform is now ready for immediate deployment, offering businesses the opportunity to streamline their sales processes through intelligent, automated conversations. For more information, visit https://ibn.fm/i4SG8.
